About: CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 May 2006

Attributes	Values
rdf:type	Item
description	article scientifique publié en 2006 (fr) наукова стаття, опублікована в травні 2006 (uk) artículu científicu espublizáu en mayu de 2006 (ast) scientific article published on 21 May 2006 (en)
publication date	wds:Q83820609-7EB0EDB5-74CD-4FF2-A913-72470291A6F7
publication date	2006-05-21 00:00:00Z (xsd:dateTime)
exact match	wds:Q83820609-9CA1E76A-26BF-4259-9BA1-87DE77358DE5
exact match	https://scigraph.springernature.com/pub.10.1038/nm1421
cites work	wds:Q83820609-0204CC3F-2334-4124-8CF3-E62627575A3C wds:Q83820609-1786DF60-9531-4460-A801-937A4E06363C wds:Q83820609-339813B3-79B8-4AD7-8E1A-9AF9B93EF4ED wds:Q83820609-412850A5-275A-46B1-986F-DA69536D8A7F wds:Q83820609-4B0C67B7-7634-49D6-A01D-E4D81C8A07F1 wds:Q83820609-4B96F751-2E8A-48B9-B47D-233941A8F6D2 wds:Q83820609-5BA3A544-2D21-4B5F-8E02-33B483136378 wds:Q83820609-5C07F585-80BE-4FD4-BBA4-2C8240CC387D wds:Q83820609-69C1DF7F-901F-4858-8C38-D61477B63FC9 wds:Q83820609-74C3CD9D-B21B-412E-A1AB-747838AE62C4 wds:Q83820609-787FE2F2-04B6-4667-9721-96A7F7F5B877 wds:Q83820609-7DEF12B2-D7B6-4F11-B76B-B88A7B7B6E25 wds:Q83820609-890085C0-8E6F-4237-BA2F-D4F2AC40067E wds:Q83820609-8A542F9F-3024-4119-B23B-3EDEC51FC842 wds:Q83820609-9E05D26D-B2EC-489E-8AF3-0D23F2414CF2 wds:Q83820609-9F36C928-C4A4-4BF8-B396-E0EABE6B43B9 wds:Q83820609-B83DBB28-55BA-4252-A436-C62F39797B85 wds:Q83820609-BE3E893E-A423-4F81-BE34-7FD812437CD6 wds:Q83820609-CC074480-993D-4C7B-A6EA-AECAD4C3D111 wds:Q83820609-CC3AE60A-614F-4341-974B-492EDE344C14 wds:Q83820609-CFADE420-CDCA-448F-822D-5B680DE71A6E wds:Q83820609-CFF33C8B-454E-4425-AFF6-8C79BAB3C9A2 wds:Q83820609-D1CADB2A-2A0B-4823-AB81-EE63AEE86C49 wds:Q83820609-D68817B6-1F84-498F-A2B5-025CF5BE3B65 wds:Q83820609-E058E717-8E04-462E-89C8-783714F0A304 wds:Q83820609-EB78D726-2AD6-4AA7-9BD8-B1FAC0F8B91B wds:Q83820609-ECA4D401-E8FB-49CD-BAF3-80C6A61EEF69 wds:Q83820609-FE53D872-4B21-4F1A-8369-AD427068FB1B
cites work	The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The endocannabinoid system as a target for therapeutic drugs. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Cannabinoids: potential anticancer agents The endocannabinoid system and its therapeutic exploitation Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Antifibrogenic role of the cannabinoid receptor CB2 in the liver Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity Hepatic fibrosis: molecular mechanisms and drug targets Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective Anandamide induces necrosis in primary hepatic stellate cells Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts
author name string	wds:Q83820609-18F9B970-F850-451F-8CDD-190E6218B804 wds:Q83820609-42D2EF24-3FDF-45B9-899C-B33849FD4057 wds:Q83820609-4E1928DF-6DD4-41CD-B46F-CFFBFA6074FF wds:Q83820609-59A80B72-9134-4703-8EEE-B32CB4067E29 wds:Q83820609-76986769-CF34-4146-B96D-3306B4365D59 wds:Q83820609-7D0817D6-4016-43D4-83B3-C0FC595E4A22 wds:Q83820609-7F156C8B-069E-4770-8851-3FB881B5C014 wds:Q83820609-B3EDB689-16A1-46C8-B81C-4A3AA9C9F30D wds:Q83820609-F6BFC0AF-D23D-4E61-9F3B-0ACF0BFCE52A
author name string	Jeanne Tran Van Nhieu Vanessa Deveaux Catherine Ledent Liying Li Ariane Mallat Fatima Teixeira-Clerc Boris Julien Pascale Grenard Valérie Serriere-Lanneau
rdfs:label	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis (en)
skos:prefLabel	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis (en)
name	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis (en)
author	wds:Q83820609-292D2B1F-FCFC-4BE2-B112-A7A3097B23B3
author	Sophie Lotersztajn
title	wds:Q83820609-1B341BB3-332B-4E45-92F3-3D80372D9142
title	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis (en)
page(s)	wds:Q83820609-DE7A87B5-D459-47CB-BE9C-10B36C969A67
page(s)	671-676
instance of	wds:Q83820609-F64E90A4-B40C-4981-834C-897983F8949A
instance of	scholarly article
PubMed ID	wds:Q83820609-7BC8A83A-82A6-43FF-B07C-67AEB129FD67
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16715087
PubMed ID	16715087
published in	wds:Q83820609-3901F626-26C2-49C8-8895-ECCBD4D1B3FC
published in	Nature Medicine
issue	wds:Q83820609-75C746E8-A5BB-4A45-9F7F-183195D9DE87

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software